A New Dementia Care Model Is Slashing Antipsychotic Use in Nursing Homes. Here Is How It Works.

A new study — A rehabilitation-driven approach to dementia care is producing measurable results in skilled nursing facilities, with new research showing significant drops in both antipsychotic prescriptions and emergency department visits among residents.

The findings, published this month in the Journal of the American Medical Directors Association, tracked outcomes across facilities that adopted an interdisciplinary care model built around the Allen Cognitive Scale. According to industry reports, the study linked this therapy-forward approach to marked reductions in medication use and hospital transfers.

The Allen Cognitive Scale, developed decades ago by occupational therapy researcher Claudia K. Allen, assesses functional cognitive levels to guide individualized care planning. Facilities using this framework integrate physical, occupational, and speech therapy into daily dementia care rather than treating therapy as a separate service.

Researchers found that residents in participating facilities experienced fewer behavioral episodes requiring chemical intervention. That translated into lower antipsychotic prescribing rates — a significant outcome given ongoing federal pressure to reduce potentially inappropriate use of these medications in nursing homes.

The emergency department visit reductions were equally notable. Industry sources note that ED transfers are both costly and disruptive for residents with dementia, often triggering delirium and functional decline. The study suggests that better on-site management of behavioral symptoms kept residents stable and out of hospitals.

“Data suggest that adopting a therapy-forward approach to a holistic, interdisciplinary care regimen yields markedly better benefits than one of general dementia management strategies and use of antipsychotic medications,” the study authors wrote.

The model emphasizes person-centered care — tailoring interventions to each resident’s cognitive level and functional abilities rather than applying one-size-fits-all protocols. Staff across disciplines collaborate on care plans, with therapists playing a central role in daily routines.

For operators, the implications extend beyond clinical outcomes. Antipsychotic reduction has been a CMS priority for years, with facilities facing public reporting requirements and potential penalties for high prescribing rates. A proven model that achieves reductions through care redesign rather than medication restrictions alone could offer a sustainable path forward.

The study adds to growing evidence that non-pharmacological interventions can effectively manage dementia-related behaviors. Previous research has shown that activities, environmental modifications, and staff training can reduce agitation without resorting to medications that carry significant side effects in elderly populations.

Whether this specific model gains broader traction will depend on implementation feasibility — particularly staffing requirements and training needs. But the results suggest that investing in therapy integration may pay dividends across multiple quality metrics.